truckcountry1.jpgOne of the world’s largest manufacturers of drugs that combat bacterial infections, cardiovascular disease and tuberculosis, Lupin Pharmaceuticals, has selected Movianto to provide warehousing and distribution services for its UK market entry. Lupin Pharmaceuticals’ warehousing and distribution operation will be run from Movianto’s Bedford operations centre and warehouse facility. From this central location, individual product lines will be picked and transported overnight via Movianto’s 30,000m2 capacity UK network of eight strategically located MHRA (Medicines and Healthcare Products Regulatory Agency) approved depots for next day delivery to wholesalers and pharmaceutical chains.

Karl Roberts, Vice President Generics, Lupin (Europe) Ltd, commented: “Our reasons for choosing Movianto for our UK market entry were twofold. Lupin required a logistics partner with access to and an innate understanding of the UK’s complex healthcare supply chain. We also required a guarantee of next day delivery with full accountability and real time access to stock levels and product location and movements to meet our projected expansion plans. Movianto fulfilled both criteria.”

Movianto will distribute Lupin Pharmaceutical product lines using its network fleet of vehicles fitted with Masternaut™ Technology satellite tracking systems. This provides a complete audit trail from the point at which Lupin’s products enter the Movianto supply chain to the point at which they leave it. In combination with its PKMS warehouse management, SAP sales order processing and centralised vehicle scheduling systems, full real-time access to the status and location of customer goods entrusted to Movianto can be provided.

Movianto’s Head of UK Sales and Marketing, David Perfrement commented, “We are only too pleased to be of service. Movianto works with many manufacturers entering the UK market. We are able to offer the benefit of our healthcare experience to aid their transition into our local market. Lupin Pharmaceuticals is one of the world’s major drug manufacturers and this represents a significant win for our business development team.”

Movianto UK Limited
Tel: 0870 870 0190
www.movianto.com

Comments are closed.